Latest Episodes
The use of IO in unresectable HCC: Part 1
In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use...
BRAF-mutated CRC: testing to treatment
Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available...
Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions
In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...
Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey
In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...
Regional differences in NET: Treatment and future developments
In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living...
Regional differences in NET: Epidemiology, diagnosis, and referral strategies
In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient...